Issue navigation
Volume 50, Issue 4, April 2011
Editorials
Ankylosing spondylitis and related spondyloarthropathies: the dramatic advances in the past decade
Rheumatology, Volume 50, Issue 4, April 2011, Pages 637–639, https://doi.org/10.1093/rheumatology/keq433
A national strategy for UK musculoskeletal clinical research: Arthritis Research UK clinical studies initiative
Rheumatology, Volume 50, Issue 4, April 2011, Pages 640–642, https://doi.org/10.1093/rheumatology/keq198
Systemic vasculitis—is it time to reclassify?
Rheumatology, Volume 50, Issue 4, April 2011, Pages 643–645, https://doi.org/10.1093/rheumatology/keq229
Reviews
FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells
Rheumatology, Volume 50, Issue 4, April 2011, Pages 646–656, https://doi.org/10.1093/rheumatology/keq328
Pregnancy and reproduction in autoimmune rheumatic diseases
Rheumatology, Volume 50, Issue 4, April 2011, Pages 657–664, https://doi.org/10.1093/rheumatology/keq350
Basic science
Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease
Rheumatology, Volume 50, Issue 4, April 2011, Pages 665–673, https://doi.org/10.1093/rheumatology/keq378
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis
Rheumatology, Volume 50, Issue 4, April 2011, Pages 674–681, https://doi.org/10.1093/rheumatology/keq372
Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus
Rheumatology, Volume 50, Issue 4, April 2011, Pages 682–688, https://doi.org/10.1093/rheumatology/keq313
Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission
Rheumatology, Volume 50, Issue 4, April 2011, Pages 689–696, https://doi.org/10.1093/rheumatology/keq375
Clinical Science
Mortality in Wegener’s granulomatosis: a bimodal pattern
Rheumatology, Volume 50, Issue 4, April 2011, Pages 697–702, https://doi.org/10.1093/rheumatology/keq351
Self-reported flaring varies during the menstrual cycle in systemic lupus erythematosus compared with rheumatoid arthritis and fibromyalgia
Rheumatology, Volume 50, Issue 4, April 2011, Pages 703–708, https://doi.org/10.1093/rheumatology/keq360
Comparison of measures of functional disability in patients with gout
Rheumatology, Volume 50, Issue 4, April 2011, Pages 709–713, https://doi.org/10.1093/rheumatology/keq387
Efficacy in current practice of switching between anti-tumour necrosis factor-α agents in spondyloarthropathies
Rheumatology, Volume 50, Issue 4, April 2011, Pages 714–720, https://doi.org/10.1093/rheumatology/keq377
Clinical significance of high levels of soluble tumour necrosis factor-α receptor-2 produced by alternative splicing in rheumatoid arthritis: a longitudinal prospective cohort study
Rheumatology, Volume 50, Issue 4, April 2011, Pages 721–728, https://doi.org/10.1093/rheumatology/keq381
Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study
Rheumatology, Volume 50, Issue 4, April 2011, Pages 729–734, https://doi.org/10.1093/rheumatology/keq369
Radiographic thumb osteoarthritis: frequency, patterns and associations with pain and clinical assessment findings in a community-dwelling population
Rheumatology, Volume 50, Issue 4, April 2011, Pages 735–739, https://doi.org/10.1093/rheumatology/keq371
Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout
Rheumatology, Volume 50, Issue 4, April 2011, Pages 740–745, https://doi.org/10.1093/rheumatology/keq346
Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease
Rheumatology, Volume 50, Issue 4, April 2011, Pages 746–755, https://doi.org/10.1093/rheumatology/keq392
Cost of illness in rheumatoid arthritis in Germany in 1997–98 and 2002: cost drivers and cost savings
Rheumatology, Volume 50, Issue 4, April 2011, Pages 756–761, https://doi.org/10.1093/rheumatology/keq398
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey
Rheumatology, Volume 50, Issue 4, April 2011, Pages 762–767, https://doi.org/10.1093/rheumatology/keq310
Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan
Rheumatology, Volume 50, Issue 4, April 2011, Pages 768–775, https://doi.org/10.1093/rheumatology/keq311
Markedly increased IL-18 liver expression in adult-onset Still’s disease-related hepatitis
Rheumatology, Volume 50, Issue 4, April 2011, Pages 776–780, https://doi.org/10.1093/rheumatology/keq397
Mechanism of coronary flow reserve reduction in systemic sclerosis: insight from intracoronary pressure wire studies
Rheumatology, Volume 50, Issue 4, April 2011, Pages 781–788, https://doi.org/10.1093/rheumatology/keq402
A high physical workload and high job demands hamper the good prognosis in physical functioning in persons with early inflammatory joint conditions
Rheumatology, Volume 50, Issue 4, April 2011, Pages 789–798, https://doi.org/10.1093/rheumatology/keq359
Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus
Rheumatology, Volume 50, Issue 4, April 2011, Pages 799–805, https://doi.org/10.1093/rheumatology/keq383
Case reports
Letters to the Editor
Safety of rituximab therapy during twins’ pregnancy
Rheumatology, Volume 50, Issue 4, April 2011, Pages 806–808, https://doi.org/10.1093/rheumatology/keq403
Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient
Rheumatology, Volume 50, Issue 4, April 2011, Pages 808–810, https://doi.org/10.1093/rheumatology/keq417
Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis
Rheumatology, Volume 50, Issue 4, April 2011, Pages 810–812, https://doi.org/10.1093/rheumatology/keq429
Matters Arising
Comment on: Steroid injection for hip osteoarthritis: efficacy under ultrasound guidance
Rheumatology, Volume 50, Issue 4, April 2011, Pages 812–813, https://doi.org/10.1093/rheumatology/ker005
Comment on: Steroid injection for hip osteoarthritis: efficacy under ultrasound guidance: reply
Rheumatology, Volume 50, Issue 4, April 2011, Page 813, https://doi.org/10.1093/rheumatology/keq451
Erratum
Erratum
Rheumatology, Volume 50, Issue 4, April 2011, Page 814, https://doi.org/10.1093/rheumatology/keq461
